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Lutheran
    G. Daniels
The Lutheran blood group system consists of 19 antigens: four 
pairs of antithetical antigens—Lua/Lub, Lu6/Lu9, Lu8/Lu14, and 
Aua/Aub—and 11 antigens of very high frequency. These antigens 
are located on four of the five immunoglobulin-like domains of 
both isoforms of the Lutheran glycoprotein. The LU gene is on 
chromosome 19 and comprises 15 exons. The two glycoprotein 
isoforms differ in the length of their cytoplasmic tails as a re-
sult of alternative splicing of intron 13. Lu
null
 phenotype arises 
from homozygosity for inactivating mutations in the LU gene. 
The dominantly inherited Lu
mod
 phenotype, In(Lu), results from 
heterozygosity for inactivating mutations in KLF1, the gene for the 
erythroid transcription binding factor EKLF. Clinically, antibod-
ies of the Lutheran system are relatively benign. When hemolytic, 
they generally cause only mild, delayed hemolytic transfusion re-
actions or hemolytic disease of the fetus and newborn that can be 
treated by phototherapy. The Lutheran glycoproteins, which are 
members of the immunoglobulin superfamily of adhesion mol-
ecules and receptors, bind isoforms of laminin with α5 chains, 
components of the extracellular matrix abundant in vascular 
endothelia. The primary function of the Lutheran glycoproteins 
on RBCs could involve the transfer of maturing 
RBCs from the bone marrow to the peripheral 
circulation. They could also be involved in vascu-
lar occlusion and thrombotic events as complica-
tions of sickle cell disease and polycythemia vera, 
respectively. 
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History 
Lutheran was the fifth blood group sys-tem to be discovered, after ABO, MN (but before S), P, and Rh. Anti-Lua, 
the first Lutheran antibody, was identified in 
1945 in a serum that also contained the first 
examples of anti-Cw and anti-Levay (which 
became anti-Kpc), plus anti-c and anti-N.1,2 
It was another 10 years before the antibody 
to the antithetical antigen, Lub, was identi-
fied.3 Lutheran is now a complex system 
comprising four pairs of antithetical anti-
gens plus 11 antigens of very high frequency 
(Table 1). In 1951 the first demonstration of 
linkage between human autosomal genes 
was between the Lutheran blood group gene 
and the gene originally believed to govern 
the Lewis blood group, but which turned out 
to be the ABO secretor gene.4
 Lu
null
 phenotype, Lu(a−b−), with complete absence of 
Lutheran antigens and a recessive mode of inheritance, was 
found in an English woman in 19605; its molecular back-
ground was resolved 47 years later.6 A phenotype called 
Lu(a−b−), but often subsequently referred to as In(Lu) phe-
notype, was discovered in 1961 by Dr. Mary (Polly) Craw-
ford, MD, in herself and in three generations of her fam-
ily.7 This phenotype, in which Lutheran antigens are barely 
detectable and there is also weakened expression of some 
other blood group antigens outside of the Lutheran system, 
has a dominant mode of inheritance. The molecular basis 
of In(Lu), heterozygosity for inactivating mutations in a 
gene for an erythroid transcription factor, was identified in 
2008.8
 Immunochemical analyses revealed that the Lutheran 
antigens were located on two isoforms of a glycoprotein.9,10 
Cloning and sequencing of the Lutheran gene in 1995,11 and 
subsequent disclosure of its organization,12,13 demonstrated 
Table 1. Antigens of the Lutheran system
Antigen Molecular basis of antigen-negative phenotype
No Name Frequency
Anti-
thetical Nucleotides Exon Amino acids
LU1 Lua Polymorphic Lub 230A>G 3 His77Arg
LU2 Lub High Lua 230G>A 3 Arg77His
LU3 Lu3 High Various






LU5 Lu5 High 326G>A 3 Arg109His
LU6 Lu6 High Lu9 824C>T 7 Ser275Phe
LU7 Lu7 High Not known
LU8 Lu8 High Lu14 611T>A 6 Met204Lys
LU9 Lu9 Low Lu6 824T>C 7 Phe275Ser
LU11 Lu11 High Not known












LU14 Lu14 Low Lu8 611A>T 6 Lys204Met
LU16 Lu16 High 679C>T 6 Arg227Cys
LU17 Lu17 High 340G>A 3 Glu114Lys
LU18 Aua Polymorphic Aub 1615A>G 12 Thr529Ala
LU19 Aub Polymorphic Aua 1615G>A 12 Ala529Thr
LU20 Lu20 High 905C>T 7 Th302Met
LU21 Lu21 High 282C>G 3 Asp94Glu
Obsolete: LU10, previously Singleton; LU15, AnWj (now 901009).
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that the Lutheran (Lu) glycoproteins are members of the 
immunoglobulin superfamily of receptors and adhesion 
molecules and differ from each other in the length of their 
cytoplasmic tails as a result of alternative splicing. Elucida-
tion of the molecular bases of the Lutheran polymorphisms 
and variants soon followed.12–14
 Clinically Lutheran is not very important, but it is a very 
interesting system from genetic and functional perspectives.
The Lutheran Gene (LU) and the Lutheran Glycopro-
teins (CD239)
 LU is located on the long arm of chromosome 19, at 
19q13.2, as part of the linkage group that includes the genes 
for the H (FUT1), secretor (FUT2), and Lewis (FUT3) gly-
cosyltransferases and for the LW blood group (ICAM4).15,16 
Lutheran cDNA was cloned from a human placental cDNA 
library by using an amino acid sequence derived from Lu-
glycoproteins purified by immunoaffinity chromatography 
with a monoclonal antibody, BRIC 221.11
 Immunoblotting of RBC membranes with monoclonal 
anti-Lub or with alloanti-Lua, -Lub, -Lu3, -Lu4, -Lu6, -Lu8, 
-Lu12, -Aua, or -Aub revealed components of apparent mo-
lecular weights of 85 and 78 kDa.9,10,17 Immunoprecipitation 
experiments with a rabbit antiserum prepared to an ami-
no acid sequence of the cytoplasmic domain showed that 
the 78-kDa structure lacks part of the cytoplasmic domain 
present in the 85-kDa isoform.11
 The Lu-glycoproteins belong to the immunoglobulin 
superfamily (IgSF),11 a large collection of glycoproteins that 
contain repeating extracellular domains with sequence ho-
mology to immunoglobulin variable (V) or constant (C1, 
C2, or I) domains. IgSF glycoproteins mostly function as 
receptors and adhesion molecules and may be involved in 
signal transduction.18 The extracellular domain of the Lu-
glycoproteins is organized into two V and three C2 IgSF 
domains,11 with a distinctive bend and flexible junction be-
tween domains 2 and 3 (Fig. 1).19,20 There are five potential 
N-glycosylation sites, one in the third domain and the other 
four in the fourth domain.
 The LU gene is organized into 15 exons: exon 1 encodes 
the signal peptide; exons 2 through 12, the five IgSF do-
mains; exon 13, the transmembrane domain and the cyto-
plasmic domain common to both isoforms; and exons 14 
and 15, the C-terminal 40 amino acids of the 85-kDa iso-
form.12,13 LU transcripts of 2.5 kb and 4.0 kb encode the 85-
kDa and 78-kDa Lu-glycoprotein isoforms, respectively.21 
The two transcripts differ as a result of alternative splicing 
of intron 13: in the 2.5-kb transcript intron 13 has been 
removed by splicing and exons 14 and 15 encode the C- 
terminal 40 amino acids of the larger isoform; in the 4.0-kb 
transcript intron 13 is retained and contains a translation-
stop codon, so the unspliced intron 13 and exons 14 and 15 
are not translated and the protein product has a cytoplas-
mic domain consisting only of the 19 amino acids encoded 
by exon 13.21 The 78-kDa transcript had previously been 
identified as an epithelial cancer antigen, and is often re-
ferred to by its earlier name, B-CAM,22 or as Lu(v13).21
The Lutheran Antigens
Lua (LU1) and Lub (LU2)  
 Lua and Lub are inherited as codominant allelic charac-
ters.15 Lua is widely distributed among Europeans, Africans, 
and North Americans, with a frequency of around 6 to 8 
percent, but it is very rare in or absent from all other in-
digenous populations studied.23 In Caucasian populations 
the incidence of Lu(b−) is about one in a thousand. Typi-
cal frequencies were obtained from tests with anti-Lua and 
-Lub on about 1500 white Canadians: Lua 6.9 percent; Lub 
99.9 percent; Lu(a−b+) 93.1 percent; Lu(a+b+) 6.8 percent; 
Lutheran
Fig. 1 Model of the Lu-glycoproteins showing the five IgSF do-
mains, the location of the Lutheran antigens, and the cytoplasmic 
domains in the two isoforms.
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Lu(a+b−) 0.1 percent; Lua allele 3.5 percent; Lub allele 96.5 
percent.24,25 All of 1102 Chinese genotyped were homozy-
gous for Lub.26
 The Lutheran antigens are very variable in strength, 
but the antigenic strength usually remains roughly constant 
within families. There is also heterogeneity of Lutheran 
antigen strength among individual RBCs within a person, 
which accounts for the characteristic mixed field agglutina-
tion patterns often seen with Lutheran antisera, especially 
anti-Lua. Occasionally adsorption and elution tests are re-
quired to detect weak Lub on Lu(a+b+) cells. RBCs from 
cord samples and from infants in the first year of life have 
markedly weakened expression of Lua and Lub compared 
with those from adults.15
 Lua/Lub results from a single nucleotide polymorphism 
(SNP) in exon 3 of LU, encoding an amino acid substitution 
in the first IgSF domain of the Lu-glycoproteins: Lua A230, 
His77; Lub G230, Arg 77 (Table 1).12,13 This SNP is associated 
with an AciI restriction-site polymorphism.13
Lu6 (LU6) and Lu9 (LU9)  
 Lu6 and Lu9, Lutheran antigens of high and low fre-
quency, respectively, have an antithetical relationship and 
represent an SNP and CfoI restriction polymorphism in LU 
encoding an amino acid substitution in the third IgSF do-
main (Table 1).14 The original anti-Lu9 was found, together 
with anti-Lua, in the serum of a white woman.27 RBCs of 
her husband were Lu(a+b+) and Lu:9. Study of his family 
showed that Lu9 expression was controlled by the LU lo-
cus, although it did not represent an allele of Lua and Lub. 
The only other example of anti-Lu9 was found in a multiply 
transfused woman and tests on 200 RBC samples unearthed 
only one Lu:9 sample (0.5%).28 Tests with the original anti-
Lu9 suggested a higher frequency of 1.7 percent,27 but that 
serum also contained anti-HLA-B7 (-Bga).29
 RBCs of the original Lu:–6 propositus and those of her 
two Lu:–6 siblings were strongly Lu:9, suggesting homozy-
gosity.30 All other Lu:–6 individuals (who are not Lu
null
) 
have also been Lu:9.
Lu8 (LU8) and Lu14 (LU14)
 Lu8 and Lu14, Lutheran antigens of high and low fre-
quency, respectively, have an antithetical relationship and 
represent an SNP and FatI and Nla restriction polymor-
phisms in LU, encoding an amino acid substitution in the 
second IgSF domain (Table 1).14 The original anti-Lu8 was 
reported as an antibody to a high-frequency antigen absent 
from Lu
null
 cells.31 An antibody in the serum of a multiply 
transfused dialysis patient, which reacted with RBCs of 
2.4 percent of random white donors, reacted strongly with 
three examples of Lu:–8 and was numbered anti-Lu14.32
Aua (LU18) and Aub (LU19): the Auberger Antigens
 The first anti-Aua was identified in 1961 in the serum 
of a multiply transfused woman.33 The antibody to 
the antithetical antigen, Aub, was not found until 1989. 
For many years the Auberger antigens were considered 
to be independent of Lutheran, despite being absent from 
In(Lu) RBCs, mainly because of results on one family, 
which showed recombination between Aua and Lua.34 After 
the demonstration that Aua and Aub are located on the Lu-
glycoproteins,17 the family was retested for Aua and tested 
for Aub; errors in the original testing were discovered and 
the family then supported linkage between Auberger and 
Lutheran.35 Family studies confirmed that Auberger and 
Lutheran antigens are controlled by the same gene.36 Aua 
has an incidence of between 80 percent and 90 percent in 
European populations.33,37 Aub has an incidence of about 
50 percent in a European population and 68 percent in an 
African American population.38 Genotyping in Chinese pre-
dicted antigen frequencies for Aua and Aub of 98 percent 
and 24 percent, respectively.26
 Aua and Aub represent an SNP in exon 12 encoding an 
amino acid substitution in the fifth IgSF domain.12
Other Lutheran Antigens
 Lu3, Lu4, Lu5, Lu7, Lu11, Lu12, Lu13, Lu16, Lu17, Lu20, 
and Lu21 are antigens of very high incidence.15,39 All are ab-
sent from Lu
null
 RBCs and absent from, or extremely weakly 
expressed on, In(Lu) cells. All except Lu11 have been shown 
to be located on the Lu-glycoproteins by immunoblotting, 
monoclonal antibody-specific immobilization of eryth-
rocyte antigens assay, or flow cytometry with K562 cells 
transfected with LU cDNA,10,12,39,40 or their absence has been 
associated with a mutation in the LU gene (Table 1).6,14,39 
Lu11 has not been shown to be inherited29 and the evidence 
that Lu11 belongs to the Lutheran system is limited, so Lu11 
should be referred to as a para-Lutheran antigen.
 Absence of most of these high-frequency antigens is as-
sociated with a single nucleotide change in LU, encoding 
an amino acid substitution, but there are some exceptions 
(Table 1). Lu3 is defined by antibodies produced by immu-
nized individuals with Lu
null
 phenotype and is described 
later. Homozygosity for two different mutations within the 
same codon has been responsible for the rare phenotype in 
the only two known unrelated Lu:−4 individuals: 524G>A 
encoding Arg175Gln and 524G>T encoding Arg175Leu.14,41 
Lu:−12 also had two different molecular backgrounds in two 
individuals: (1) a six-nucleotide deletion in exon 2 encoding 
a deletion of Arg34 and Leu35; (2) 419G>A in exon 3 en-
coding Arg140Gln.14 Although the mutations are in differ-
ent exons, when mapped to a three-dimensional schematic 
presentation of the Lu-glycoprotein the amino acid changes 
appeared to be located in close spatial proximity because of 
the protein folding.14 It is likely that the mutations altered 
the same epitope on the Lu-glycoprotein, affecting binding 
of the anti-Lu12. Lu:−12 was associated with weak expres-
sion of Lub in the original family and in an Lu:−12 individual 
found by screening 1050 Canadian donors with anti-Lu12.42 
Lu12 and Lub are both located on the first IgSF domain, so 
G. Daniels
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Lutheran system antibody has been detected in the serum 
of any person with an In(Lu) gene, presumably because of 
the weak expression of Lutheran system antigens on their 
RBCs.
 A large survey of about 250,000 London blood donors 
with anti-Lub and -Lua revealed 79 Lu(a−b−) donors, an in-
cidence of about 0.03 percent.49 Most of these were prob-
ably In(Lu). A similar incidence was found by screening 
African Americans in Detroit.50 Screening of US donors in 
Houston and Portland with monoclonal anti-CD44 or with 
anti-AnWj, which would be more specific for In(Lu), gave 
frequencies of 0.02 percent and 0.12 percent, respective-
ly.51,52
 The term In(Lu) is not really appropriate as the In(Lu) 
phenotype is also characterized by weakened expression of 
RBC antigens belonging to other blood group systems:
P1, although the effect is less obvious than that of the • 
Lutheran antigens49,53;
i antigen as judged by selected anti-i• 49,53;
CD44, and consequently the high-frequency In• b (IN2), 
INFI (IN3), and INJA (IN4) antigens located on CD44, 
although these determinants are still easily detected on 
In(Lu) RBCs54,55;
AnWj, an antigen of very high incidence, which may be • 
associated with the CD44 glycoprotein, is not expressed, 
or at least is expressed only very weakly56;
Kn• a, McCa, Sla, and Yka of the Knops system (CD35),57 
Csa,57 and MER2 (CD151),15 although the effect is slight 
and family studies are required.
 Individuals with an In(Lu) gene are generally healthy 
with no obvious anemia or reticulocytosis, although a de-
gree of acanthocytosis has been associated with In(Lu).58
 Singleton et al.8 demonstrated that In(Lu) resulted from 
heterozygosity for mutations in KLF1, in the presence of a 
normal KLF1 allele. KLF1 encodes the erythroid transcrip-
tion factor erythroid Kruppel-like factor (EKLF), which 
is essential for terminal differentiation of erythroid cells. 
The following mutations were detected: two nonsense, two 
frameshift, four encoding single amino acid substitutions, 
and one single nucleotide change in the promoter region.
Lumod of the X-linked Type
 In another type of Lu
mod
, found in just one large Austra-
lian family, the mode of inheritance showed the character-
istics of resulting from a recessive X-borne inhibitor gene.59 
All the Lu
mod
 members were males, and although the Lu
mod 
phenotype occurred in successive generations, there was no 
example of transmission of the phenotype from parent to 
child. The regulator locus is called XS; XS1 is the common 
allele and XS2 the rare inhibitor allele. The Lu
mod
 RBCs were 
Lu(a–b–) and lacked the other Lutheran antigens, yet anti-Lub 
could be adsorbed and eluted from the RBCs. The RBCs were 
AnWj+, appeared to have slightly enhanced i antigen, and had 
weak P1 antigens, although this may have been attributable to 
the presence of a weak P1 gene in the family.
the Lub weakening may result from conformational changes 
caused by the amino acid changes arising from the Lu:−12 
mutations.
Recombinant Lutheran Antigens
 Lutheran antigens have been used as models for the 
application of recombinant proteins in antibody identifi-
cation.12,43,44 Recombinant proteins containing all or some 
of the IgSF domains of the Lutheran protein have been 
expressed in eukaryotic or prokaryotic cells. The purified 
protein was then used in agglutination inhibition tests, 
attached to polystyrene plates for detection by an ELISA 
procedure, or coupled to superparamagnetic particles for 
detection in a particle gel immunoassay.43–45 Alloanti-Lua 
or -Lub, as specified by the cDNA transfected, was detected 
with high sensitivity and specificity.
Lunull and Lumod Phenotypes
Lunull
 The only true Lu
null
 phenotype is extremely rare and has 
a recessive mode of inheritance. No antigens of the Lu-
theran system can be detected on the RBCs, and individuals 
with the Lu
null
 phenotype may make an antibody, anti-Lu3, 





 RBCs have normal expression of those an-
tigens, such as AnWj, that are expressed weakly on In(Lu) 
RBCs.
 The molecular background of Lu
null
 has been identified 
in five individuals. All are either homozygous or doubly 
heterozygous for inactivating mutations in the LU gene.
English woman.1. 5 Heterozygosity for a nonsense muta-
tion 691C>T in exon 6, encoding Arg231STOP, and for 
a deletion of exons 3 and 4.6
Japanese blood donor. Homozygosity for a nonsense 2. 
mutation 711C>A in exon 6 encoding Cys237STOP.6
German woman of Czech origin. Homozygosity for a 3. 
nonsense mutation 361C>T in exon 3 encoding Arg-
121STOP.6
Japanese blood donor. Homozygosity for a 27-kb dele-4. 
tion encompassing exons 3 to 15 of LU.46
Pregnant Dutch Caucasian woman. Homozygosity for 5. 




 In(Lu) was the name given for a rare, dominant sup-
pressor of the Lutheran antigens and has subsequently also 
been used to describe the phenotype. RBCs of most individ-
uals with an In(Lu) gene appear to be Lu(a−b−) and Lu
null
 
by agglutination tests, but will bind selected Lutheran anti-
bodies, as determined by adsorption and elution tests. Ad-
sorption and elution tests with anti-Lua and -Lub permitted 
the determination of the Lutheran genotype in some In(Lu) 
members of families, which demonstrated that the In(Lu) 
suppressor gene is not inherited at the LU locus.48 No 
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Lutheran Antibodies and Their Clinical Significance     
 If Lutheran antibodies are implicated in hemolytic 
transfusion reactions, they are almost always mild and de-
layed,15 although there could be exceptions.60 Lutheran an-
tibodies have not been reported to have caused hemolytic 
disease of the fetus and newborn severe enough to require 
any treatment beyond phototherapy.15 Lua antibodies may 
be naturally occurring or immune and are often IgM, but 
may also be IgG and IgA. They are usually reactive by direct 
agglutination of Lu(a+) RBCs, but often also react by an in-
direct antiglobulin test (IAT). Antibodies to Lub and other 
Lutheran antigens are most often IgG, predominantly IgG1, 
although IgM or IgA may be present. Most anti-Lub RBCs 
react best by IAT, but some are directly agglutinating with a 
temperature optimum of 20°C.
 Monoclonal anti-Lub has been produced from mice im-
munized with Lu(b+) RBCs,9 and a single-chain variable 
fragment (scFv) with Lua specificity has been produced by 
phage display and recombinant DNA technology.61
 Lutheran antibodies react with papain-treated RBCs, 
but not with trypsin- or α-chymotrypsin-treated RBCs. 
RBCs treated with 6 percent 2-aminoethylisothiouronium 
bromide (AET) or with 200 mM dithiothreitol (DTT) do 
not usually react with Lutheran antibodies. This should be 
expected considering that Lutheran antigens are located 
in disulfide-bonded IgSF domains and sulfhydryl reducing 
agents, such as AET and DTT, break disulfide bonds, un-
folding the protein.
Functional Aspects of the Lutheran Glycoproteins
 In addition to RBCs, the Lu-glycoproteins are present 
on vascular endothelial cells and epithelial cells of multiple 
tissues.11,21 The Lu-glycoproteins bind laminin, a compo-
nent of the extracellular matrix (ECM) abundant in base-
ment membranes and also present in vascular endothelia. 
The 15 known types of laminin are composed of different 
isoforms of three protein chains (α, β, γ). Lu-glycoproteins 
bind specifically and with high affinity to the two isoforms 
of laminin that contain α5 chains (511 and 521).62,63 The 
laminin binding site is formed by Asp312 and a surround-
ing group of negatively charged residues in the region of 
the flexible linker between IgSF domains 2 and 3 of the Lu-
glycoproteins (Fig. 1).19
 During in vitro erythropoiesis, the Lu-glycoproteins 
appear on the erythroid cells at about the orthochromatic 
erythroblast stage.64,65 This late appearance correlates with 
binding of the cells to laminin.66 The presence of lami-
nin 511/521 on the subendothelium basement membrane 
of bone marrow sinusoids has led to speculation that the 
Lu-glycoproteins are involved in facilitating movement of 
maturing erythroid cells from the erythroblastic islands of 
the bone marrow, across the sinusoidal endothelium, to the 
peripheral circulation.62,64 The Lu-glycoproteins may also 
play a role in the migration of erythroid progenitors from 
the fetal liver to the bone marrow.11 No obvious pathologic 






 The IgSF glycoproteins expressing Lutheran and LW 
blood group activity are overexpressed on SS RBCs in sickle 
cell disease. Enhanced binding of the Lu-glycoproteins to 
laminin 511/521 on the endothelia of inflamed or damaged 
blood vessels could contribute to blockage of the vessels 
and the painful episodes of vaso-occlusion often suffered by 
sickle cell patients.67 Although laminin 511 and 521 are usu-
ally considered unique ligands of the Lu-glycoproteins, the 
integrin α4β1 (VLA-4) on SS reticulocytes may also bind Lu-
glycoproteins on endothelial cells, contributing to the vaso-
occlusion.68 Phosphorylation of Lu-glycoprotein serines 
596, 598, and 621 in RBCs, stimulated by the physiologic 
stress mediator epinephrine, could induce conformational 
changes to the external domains of these proteins, modu-
lating their attraction to their corresponding ligands on 
endothelial cells.67,69
 Polycythemia vera (PV) is a chronic myeloproliferative 
disease in which clonal proliferation of multipotent he-
mopoietic cells results in an increase in the RBC mass. It is 
usually associated with a somatic mutation in the gene for 
JAK2 tyrosine kinase and is often complicated by thrombotic 
events. The Lu-glycoproteins are phosphorylated in PV, but 
not in normal cells under the same conditions. Expression 
in an erythroid cell line of recombinant JAK2 containing the 
PV mutation potentiated Lu-glycoprotein phosphorylation. 
As phosphorylation of the Lu-glycoproteins increases RBC 
adhesion, this led to the proposal that increased RBC adhe-
siveness may be a factor promoting thrombosis in PV.70
 Both Lu-glycoprotein isoforms interact directly with 
spectrin of the cytoskeleton, through Arg-Lys at positions 
573 and 574 of their cytoplasmic tails.71 This interaction with 
spectrin appears to modulate the adhesive activity of the 
Lu-glycoproteins as disruption of the interaction resulted 
in weakened linkage to the cytoskeleton and enhanced ad-
hesion of RBCs to laminin.72 An et al.72 speculate that phos-
phorylation of the cytoplasmic tail of the Lu-glycoproteins 
weakens its interaction with spectrin, enabling the freely 
floating transmembrane molecules to cluster and generate 
a larger adhesive force.
 It is becoming clear that the Lutheran blood group, 
which is of minor clinical importance in transfusion medi-
cine, may play a much more substantial role in the pathol-
ogy of sickle cell disease or PV.
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